Plasma B-type natriuretic peptide and anti-inflammatory cytokine interleukin-10 levels predict adverse clinical outcome in chronic heart failure patients with depressive symptoms: A 1-year follow-up study

European Journal of Heart Failure

Volumn 11, Issue 10, 2009, Pages 967-972

  Parissis, John T ^a   Farmakis, Dimitrios ^a   Nikolaou, Maria ^a   Birmpa, Dionysia ^a   Bistola, Vassiliki ^a   Paraskevaidis, Ioannis ^a   Ikonomidis, Ignatios ^a   Gaitani, Stavroula ^a   Venetsanou, Koula ^a   Filippatos, Gerasimos ^a   Kremastinos, Dimitrios Th ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

Biomarkers; Depression; Heart failure; Inflammation; Prognosis

Indexed keywords

ALDOSTERONE ANTAGONIST; ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE FREE SURVIVAL; EXERCISE; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; ANALYSIS OF VARIANCE; CAUSE OF DEATH; CHRONIC DISEASE; COHORT STUDIES; CYTOKINES; DEPRESSION; DISEASE-FREE SURVIVAL; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-10; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; PROBABILITY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS;

EID: 70349659934     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfp125     Document Type: Article

References (33)

1. Havranek EP, Ware M, Lowes BD. Prevalence of depression in patients with congestive heart failure. Am J Cardiol 1999;84:348-350.
2. Koenig H. Depression in hospitalized older patients with congestive heart failure. Gen Hosp Psychiatry 1998;20:29-43.
3. Skotzko C, Krichten C, Zietowski G, Alves L, Freudenberger R, Robinson S, Fisher M, Gottlieb SS. Depression is common and precludes accurate assessment of functional status in elderly patients with congestive heart failure. J Card Fail 2000;6:300-305.
4. Jiang W, Alexander J, Christopher E, Kuchibhatta M, Gaulden LH, Cuffe MS, Krishnan RR, O'Connor CM. Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med 2001;161:1849-1856.
5. Gottlieb SS, Khatta M, Friedmann E, Einbinder L, Katzen S, Baker B, Marshall J, Minshall S, Robinson S, Fisher ML, Potenza M, Sigler B, Baldwin C, Thomas SA. The influence of age, gender, and race on the prevalence of depression in heart failure patients. J Am Coll Cardiol 2004;43:1542-1549. (Pubitemid 38561331)
6. Rutledge T, Reis VA, Linke SE, Greenberg BH, Mills PJ. Depression in heart failure: a meta-analytic review of prevalence, intervention effects and association with clinical outcomes. J Am Coll Cardiol 2006;48:1527-1537.
7. Parissis JT, Fountoulaki K, Paraskevaidis I, Kremastinos DT. Depression in chronic heart failure: novel pathophysiological mechanisms and therapeutic approaches. Expert Opin Investig Drugs 2005;14:1-8.
8. Parissis JT, Nikolaou M, Farmakis D, Bistola V, Paraskevaidis IA, Adamopoulos S, Filippatos G, Kremastinos D. Clinical and prognostic implications of self-rating depression scales and plasma B-type natriuretic peptide in hospitalised patients with chronic heart failure. Heart 2008;94:585-589.
9. Ingle L, Rigby AS, Nabb S, Jones PK, Clark AL, Cleland JG. Clinical determinants of poor six-minute walk test performance in patients with left ventricular systolic dysfunction and no major structural disease. Eur J Heart Fail 2006;8:321-325.
10. Rumsfeld JS, Havranek E, Masoudi FA, Peterson ED, Jones P, Tooley JF, Krumholz HM, Spertus JA. Depressive symptoms are the strongest predictors of short-term decline in health status in patients with heart failure. J Am Coll Cardiol 2003;42:1811-1817.
11. Sullivan M, Levy W, Crane B, Russo JE, Spertus J. Usefulness of depression to predict time to combined end point of transplant or death for outpatients with advanced heart failure. Am J Cardiol 2004;94:1577-1580.
12. Faris R, Purcell H, Henein MY, Coats AJ. Clinical depression is common and significantly associated with reduced survival in patients with non-ischemic disease. Eur J Heart Fail 2002;4:541-551.
13. Faller H, Stork S, Schowalter M, Steinbuchel T,Wollner V, Ertl G, Angermann CE. Depression and survival in chronic heart failure: does gender play a role? Eur J Heart Fail 2007;9:1018-1023.
14. Macchia A, Monte S, Pellegrini F, Romero M, D'Ettorre A, Tavazzi L, Tognoni G, Maggioni AP. Depression worsens outcomes in elderly patients with heart failure: an analysis of 48,117 patients in a community setting. Eur J Heart Fail 2008;10: 714-721.
15. Pasic J, Levy WC, Sullivan M. Cytokines in depression and heart failure. Psychosom Med 2003;65:181-193.
16. Parissis JT, Adamopoulos S, Rigas A, Kostakis G, Karatzas D, Venetsanou K, Kremastinos D. Comparison of circulating pro-inflammatory cytokines and soluble apoptosis mediators in patients with chronic heart failure with versus without symptoms of depression. Am J Cardiol 2004;94:1326-1328. (Pubitemid 39469963)
17. Joynt KE, Whellan DJ, O'Connor CM. Why is depression bad for the failing heart? A review of the mechanistic relationship between depression and heart failure. J Card Fail 2004;103:258-270.
18. Wiedemann K, Jahn H, Kellner M. Effects of natriuretic peptides upon hypothalamo-pituitary-adrenocortical system activity and anxiety behaviour. Exp Clin Endocrinol Diabetes 2000;108:5-13.
19. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, StrÖmberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. Eur J Heart Fail 2008;10:933-989.
20. Zung WWK, Richards CB, Short MJ. Self-rating depression scale in an outpatient clinic. Arch Gen Psychiatry 1965;13:508-515.
21. Von Haehling S, Jankowska EA, Anker SD. Tumour necrosis factor-a and the failing heart: pathophysiology and therapeutic implications. Basic Res Cardiol 2004;99:18-28.
22. Adamopoulos S, Parissis JT, Kremastinos DT. Endothelial dysfunction in chronic heart failure: clinical and therapeutic implications. Eur J Intern Med 2002;13: 233-239. (Pubitemid 34627052)
23. Adamopoulos S, Parissis JT, Kremastinos DT. A glossary of circulating cytokines in chronic heart failure. Eur J Heart Fail 2001;3:517-526.
24. Seta Y, Shan K, Bozkurt B, Oral H, Mann DL. Basic mechanisms in heart failure: the cytokine hypothesis. J Card Fail 1996;2:243-249.
25. Maes M, Meltzer H, Bosmans E, Bergmans R, Vandoolaeghe E, Rajah R, Desnyder R. Increased plasma concentrations of interleukin-6, soluble interleukin-6 receptor, soluble interleukin-2 receptor and transferring receptor in major depression. J Affect Disord 1995;34:301-309.
26. Moorman AJ, Mozaffarian D, Wilkinson CW, Lawler RL, McDonald GB, Crane BA, Spertus JA, Russo JE, Stempien-Otero AS, Sullivan MD, Levy WC. In patients with heart failure elevated soluble TNF-receptor-1 is associated with higher risk of depression. J Card Fail 2007;13:738-743.
27. Ferketich AK, Ferguson JP, Binkley PF. Depressive symptoms and inflammation among heart failure patients. Am Heart J 2005;150:132-136.
28. Miller GE, Stetler CA, Carney RM, Freedland KE, Banks WA. Clinical depression and inflammatory risk markers for coronary artery disease. Am J Cardiol 2002;90: 1279-1283.
29. Maes M, Bosmans E, Meltzer HY, Sharpe S, Suy E. Interleukin-1b: a putative mediator of HPA axis hyperactivity in major depression? Am J Psychiatry 1993; 150:1189-1193.
30. Kaur K, Dhingra S, Slezak J, Sharma AK, Bajaj A, Singal PK. Biology of TNF alpha and IL-10 and their imbalance in heart failure. Heart Fail Rev 2009;14:113-123.
31. Stumpf C, Lehner C, Yilmaz A, Daniel WG, Garlichs CD. Decrease of serum levels of the anti-inflammatory cytokine interleukin-10 in patients with advanced chronic heart failure. Clin Sci (Lond) 2003;105:45-50.
32. Stumpf C, Petzi S, Seybold K, Wasmeier G, Arnold M, Raaz D, Yilmaz A, Daniel WG, Garlichs CD. Atorvastatin enhances interleukin-10 levels and improves cardiac function in rats after acute myocardial infarction. Clin Sci (Lond) 2009;116:45-52.
33. Fedorac RN, Gang IA, Elson CO, Rutgeerts P, Schreiber S, Wild G, Hanauer SB, Kilian A, Cohard M, LeBeaut A, Feagan B. Recombinant human interleukin-10 in the treatment of patients with mild to moderately active Crohn's disease. The interleukin-10 Inflammatory Bowel Disease Cooperative Study Group. Gastroenterology 2000;119:1781-1783.